Heading Higher? Asensus Surgical Inc (NYSEAMERICAN:ASXC) Is In News

Asensus Surgical Inc (NYSEAMERICAN:ASXC) continues to move and up almost 1205 in just one month. Will the rally continue?

Market Action

As of 10:01, ASXC stock jumped by 4.32% at $3.62. The stock has traded 3.52 million shares, compared to  its average volume of 11.67 million shares.  The stock opened at $3.66 and moved in a range of $3.5111 – 3.7500.

Major Trigger:

Asensus Surgical to Join the Russell 2000® and Russell Microcap® Indexes

Key Highlights:

  • today announced that the company will be added to the Russell 2000® and Russell Microcap® Indexes at the conclusion of the 2021 Russell indexes annual reconstitution, effective after the US market opens on June 28, according to a preliminary list of additions posted June 4.
  • Annual Russell indexes reconstitution captures the 4,000 largest US stocks as of May 7, 2021, ranking them by total market capitalization. Membership in the US all-cap Russell 3000® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Index or small-cap Russell 2000® Index as well as the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes.
  • Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Approximately $10.6 trillion in assets are benchmarked against Russell’s US indexes. Russell indexes are part of FTSE Russell, a leading global index provider.

Key Quote

“We’re thrilled to be a part of the Russell 2000 Index and believe that our inclusion will increase our visibility and exposure to investors,” said Anthony Fernando, President and CEO of Asensus Surgical. “This milestone is a testament to our hard work to create value for our stockholders through our strategy and bring the Senhance System’s transformative technology to surgeons, hospitals, and patients globally.”

Related Posts

About The Author